Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Dec;39(12):676-685.
doi: 10.1055/s-0037-1608867. Epub 2017 Nov 27.

Is Ovarian Cancer Prevention Currently Still a recommendation of Our Grandparents?

Affiliations
Review

Is Ovarian Cancer Prevention Currently Still a recommendation of Our Grandparents?

Millena Prata Jammal et al. Rev Bras Ginecol Obstet. 2017 Dec.

Abstract

Ovarian cancer is the leading cause of death among gynecologic tumors because in most of the cases (75%), the disease is diagnosed in advanced stages. Screening methods are not available since the disease is rare, and the tested methods, such as ultrasound and CA125, were not able to decrease the mortality rate for this type of cancer. This article discusses the main risk factors for ovarian cancer, and the potential clinical and surgical strategies for the prevention of this disease.

O câncer de ovário é a principal causa de morte entre os tumores ginecológicos, já que na maioria dos casos (75%) o diagnóstico ocorre em estádios avançados. Métodos de rastreamento não estão disponíveis, já que a doença é rara, e os métodos diagnósticos, como ultrassonografia e CA 125, não são capazes de reduzir a taxa de mortalidade desse câncer. Este artigo discute os principais fatores de risco para o câncer de ovário e as possíveis estratégias clínicas e cirúrgicas para a prevenção dessa doença.

PubMed Disclaimer

Conflict of interest statement

Conflicts to Interest: None to declare.

Figures

Fig. 1
Fig. 1
Risk factors associated to ovarian cancer. Abbreviations: BRCA, breast cancer.

References

    1. Jia L, Ren J M, Wang Y Y et al.Inhibitory role of prohibitin in human ovarian epithelial cancer. Int J Clin Exp Pathol. 2014;7(05):2247–2255. - PMC - PubMed
    1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(05):277–300. - PubMed
    1. Jelovac D, Armstrong D K. Recent progress in the diagnosis and treatment of ovarian cancer. CA Cancer J Clin. 2011;61(03):183–203. - PMC - PubMed
    1. American Cancer Society. Cancer Facts & Figures 2017 Atlanta, GA: ACS; 2017. https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts.... Accessed March 10, 2017
    1. Gadducci A, Cosio S, Zola P, Landoni F, Maggino T, Sartori E. Surveillance procedures for patients treated for epithelial ovarian cancer: a review of the literature. Int J Gynecol Cancer. 2007;17(01):21–31. - PubMed